Innate Pharma Overview
Innate Pharma target price — quarterly history, peer benchmarks, and growth trends.
Get informed when a big investor buys or sells
+ Follow$1.79
No recommendations in the last 4 months.
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-10-29 | H.C. Wainwright | $5 |  180.1% upside |  |
| 2025-09-17 | Leerink Partners | $2 | 12% upside | |
Stockcircle tracks target price for Innate Pharma (IPHA), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.
This Target Price page is built for Innate Pharma's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.
Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main IPHA overview so you can move from this figure to the surrounding analysis quickly.
